Abstract:Autosomal dominant Alzheimer's Disease (ADAD) mutation carriers will develop early-onset Alzheimer's disease (AD) in the future with near 100% certainty and provide a unique opportunity to characterize the earliest biological changes associated with the predisposition to develop AD. We previously reported that presenilin-1 (PSEN1) E280A mutation–carrying children from the world's largest ADAD kindred in Colombia have structural and functional connectivity MRI abnormalities, along with plasma biomarker findings consistent with Aβ1–42 overproduction. In this study, cross-sectional measures of cognitive, behavioral and socio-emotional functioning were assessed in PSEN1 mutation–carrying children, decades before the kindred's estimated median age 44 of mild cognitive impairment. Two-hundred-sixteen children (108 PSEN1 E280A carriers, 108 non-carriers), aged 8 to 17 years, were recruited from the Alzheimer's Prevention Initiative Colombia Registry. Participants were administered the Evaluacion Neuropsicologica Infantil-ENI, assessing memory, language and attention/executive function, and the Wechsler Intelligence Scale for Children-IV (WISC-IV), measuring general intelligence (verbal and non-verbal abilities, working memory, and processing speed). Parent-Child dyads completed the Behavior Assessment System for Children-2, assessing socio-emotional and behavioral functioning. Families and raters remained blind to the participant's genetic test results. Regression models examined the associations between cognitive and behavioral measurements and age in the mutation carrier and non-carrier groups. Compared to non-carriers, PSEN1 mutation carriers had lower mean scores on the WISC-IV Verbal Comprehension (p=0.01) and Processing Speed domains (p=0.04). Self-report measures revealed lower mean scores for carriers in Interpersonal Relations, skills which are necessary for interacting successfully with peers and adults (p=0.04). Age-associated differences between groups were seen in ENI subtests of attention (p=0.02). There were no differences in memory, complex attention, executive function or other cognitive domains. Results describe the earliest known cognitive and social vulnerabilities associated with ADAD. Findings suggest that children at genetic risk for ADAD have verbal, attention, and social vulnerabilities, even before the kindred's previously reported ages of 23 and 28 at the respective onset of CSF and PET indicators of fibrillar amyloid-β deposition. It remains to be clarified whether each of these alterations are developmental or reflective of the earliest progressive changes associated with preclinical AD.

Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer's disease in a multigenerational Colombian Family.

Genetic Contributions to Alzheimer's Disease and Frontotemporal Dementia in Admixed Latin American Populations

A familial missense variant in the Alzheimer's disease gene SORL1 impairs its maturation and endosomal sorting

Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation

Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease

COGNITIVE VULNERABILITIES IN PRESENILIN-1 E280A MUTATION-CARRYING CHILDREN FROM THE WORLD’S LARGEST AUTOSOMAL-DOMINANT ALZHEIMER’S DISEASE KINDRED

[O1–13–02]: COGNITIVE VULNERABILITIES IN PRESENILIN‐1 E280A MUTATION‐CARRYING CHILDREN FROM THE WORLD's LARGEST AUTOSOMAL‐DOMINANT ALZHEIMER's DISEASE KINDRED

The first genome-wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer's disease

Haploinsufficiency of lysosomal enzyme genes in Alzheimer’s disease

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protection

The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease

African origin haplotype protective for Alzheimer′s disease in carriers: exploring potential mechanisms

Multi-omics Characterization of Epigenetic and Genetic Risk of Alzheimer Disease in Autopsied Brains from two Ethnic Groups

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease

A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's disease

E280A PS-1 Mutation Causes Alzheimer's Disease but Age of Onset is Not Modified by ApoE Alleles

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection

Patient with PSEN1 Glu318Gly and Other Possible Disease Risk Mutations, Diagnosed with Early Onset Alzheimer's Disease

Exosomal mRNA Signatures as Predictive Biomarkers for Risk and Age of Onset in Alzheimer's Disease

Association of GWAS Top Genes With Late-Onset Alzheimer's Disease in Colombian Population

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease